Chimerix NASDAQ: CMRX www.chimerix.com
Durham, US · Founded 2003 · 3,654 employees on LinkedIn · 7 known investors
Find your way into Chimerix NASDAQ: CMRX www.chimerix.com
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
Founders & leadership
MS
Mike ShermanChief Executive Officer and President
WG
W. Garrett NicholsChief Medical Officer
MA
Michael A. AlrutzExecutive
RL
Randall LanierChief Science Officer
RW
Roy W. WareChief Manufacturing and Technology Officer
HK
Heather Knight-TrentVice President of Regulatory Affairs
ON
Odin NadererinExecutive
Board
RC
Ronald C. Renaud, JrBoard director
MJ
Martha J. DemskiBoard director
JM
James M. DalyBoard director
CL
Catherine L. GillissBoard director
EF
Edward F. Greissing, Jr.Board director
Investors · 7
Reported raises · per SEC filings
Form D private placements$34.9M disclosed across 1 round · 2019
▶$34.9MraisedJul 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$34.9MraisedJul 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mike ShermanExecutive Officer, Director
- Ronald C. Renaud, JrDirector
- W. Garrett NicholsExecutive Officer
- Michael A. AlrutzExecutive Officer
- Randall LanierExecutive Officer
- Roy W. WareExecutive Officer
- Heather Knight-TrentExecutive Officer
- Odin NadererExecutive Officer
- Martha J. DemskiDirector
- James M. DalyDirector
- Catherine L. GillissDirector
- Edward F. Greissing, Jr.Director
- Patrick MachadoDirector
- Robert J. MeyerDirector
- Fred A. MiddletonDirector
- Mike AndrioleExecutive Officer
- Offering amount
- $34.9M
- Amount sold
- $34.9M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Chimerix NASDAQ: CMRX www.chimerix.com do?
- Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
- Who are Chimerix NASDAQ: CMRX www.chimerix.com's investors?
- Chimerix NASDAQ: CMRX www.chimerix.com's investors include Aisling Capital, Alta Partners, Asset Management Company, Canaan Partners, Frazier Life Sciences, Pappas Capital, Sanderling Ventures.
- How much funding has Chimerix NASDAQ: CMRX www.chimerix.com raised?
- Chimerix NASDAQ: CMRX www.chimerix.com has disclosed $34.9M raised across 1 round.
- Where is Chimerix NASDAQ: CMRX www.chimerix.com headquartered?
- Chimerix NASDAQ: CMRX www.chimerix.com is headquartered in Durham, US.